PMC:7212965 / 71755-72250 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T171","span":{"begin":246,"end":251},"obj":"Body_part"}],"attributes":[{"id":"A171","pred":"fma_id","subj":"T171","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":" Wen, 202033All Shenzhen CityGuangdongDates: 1/1/2020-2/28/2020Last follow-up: 2/28/2020 n = 417Survival: 0.7% died, 71.7% discharged, 27.6% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR.Age: m 45.4 ySex: 52.8% femalesGI/liver comorbidities: NRDisease severity: 8.9% mild, 82.5% moderate, 8.6% severe/critical Diarrhea: 7.0% (29)Present on admission.23/381 of mild/moderates and 6/36 of severe/criticalNausea, vomiting, and abdominal pain: NR ALT, AST, and bilirubin: NR"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T136","span":{"begin":246,"end":251},"obj":"Body_part"}],"attributes":[{"id":"A136","pred":"uberon_id","subj":"T136","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":" Wen, 202033All Shenzhen CityGuangdongDates: 1/1/2020-2/28/2020Last follow-up: 2/28/2020 n = 417Survival: 0.7% died, 71.7% discharged, 27.6% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR.Age: m 45.4 ySex: 52.8% femalesGI/liver comorbidities: NRDisease severity: 8.9% mild, 82.5% moderate, 8.6% severe/critical Diarrhea: 7.0% (29)Present on admission.23/381 of mild/moderates and 6/36 of severe/criticalNausea, vomiting, and abdominal pain: NR ALT, AST, and bilirubin: NR"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T352","span":{"begin":187,"end":195},"obj":"Disease"},{"id":"T353","span":{"begin":335,"end":343},"obj":"Disease"}],"attributes":[{"id":"A352","pred":"mondo_id","subj":"T352","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A353","pred":"mondo_id","subj":"T353","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"}],"text":" Wen, 202033All Shenzhen CityGuangdongDates: 1/1/2020-2/28/2020Last follow-up: 2/28/2020 n = 417Survival: 0.7% died, 71.7% discharged, 27.6% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR.Age: m 45.4 ySex: 52.8% femalesGI/liver comorbidities: NRDisease severity: 8.9% mild, 82.5% moderate, 8.6% severe/critical Diarrhea: 7.0% (29)Present on admission.23/381 of mild/moderates and 6/36 of severe/criticalNausea, vomiting, and abdominal pain: NR ALT, AST, and bilirubin: NR"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T532","span":{"begin":45,"end":48},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T533","span":{"begin":246,"end":251},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T534","span":{"begin":246,"end":251},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T535","span":{"begin":378,"end":381},"obj":"http://purl.obolibrary.org/obo/CLO_0001320"},{"id":"T536","span":{"begin":378,"end":381},"obj":"http://purl.obolibrary.org/obo/CLO_0001321"},{"id":"T537","span":{"begin":406,"end":408},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"}],"text":" Wen, 202033All Shenzhen CityGuangdongDates: 1/1/2020-2/28/2020Last follow-up: 2/28/2020 n = 417Survival: 0.7% died, 71.7% discharged, 27.6% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR.Age: m 45.4 ySex: 52.8% femalesGI/liver comorbidities: NRDisease severity: 8.9% mild, 82.5% moderate, 8.6% severe/critical Diarrhea: 7.0% (29)Present on admission.23/381 of mild/moderates and 6/36 of severe/criticalNausea, vomiting, and abdominal pain: NR ALT, AST, and bilirubin: NR"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T45976","span":{"begin":465,"end":467},"obj":"Chemical"},{"id":"T37216","span":{"begin":473,"end":476},"obj":"Chemical"},{"id":"T76753","span":{"begin":482,"end":491},"obj":"Chemical"},{"id":"T36355","span":{"begin":493,"end":495},"obj":"Chemical"}],"attributes":[{"id":"A22424","pred":"chebi_id","subj":"T45976","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"},{"id":"A964","pred":"chebi_id","subj":"T37216","obj":"http://purl.obolibrary.org/obo/CHEBI_76649"},{"id":"A21613","pred":"chebi_id","subj":"T76753","obj":"http://purl.obolibrary.org/obo/CHEBI_16990"},{"id":"A53786","pred":"chebi_id","subj":"T36355","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"}],"text":" Wen, 202033All Shenzhen CityGuangdongDates: 1/1/2020-2/28/2020Last follow-up: 2/28/2020 n = 417Survival: 0.7% died, 71.7% discharged, 27.6% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR.Age: m 45.4 ySex: 52.8% femalesGI/liver comorbidities: NRDisease severity: 8.9% mild, 82.5% moderate, 8.6% severe/critical Diarrhea: 7.0% (29)Present on admission.23/381 of mild/moderates and 6/36 of severe/criticalNausea, vomiting, and abdominal pain: NR ALT, AST, and bilirubin: NR"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T327","span":{"begin":335,"end":343},"obj":"Phenotype"},{"id":"T328","span":{"begin":435,"end":443},"obj":"Phenotype"},{"id":"T329","span":{"begin":449,"end":463},"obj":"Phenotype"}],"attributes":[{"id":"A327","pred":"hp_id","subj":"T327","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A328","pred":"hp_id","subj":"T328","obj":"http://purl.obolibrary.org/obo/HP_0002013"},{"id":"A329","pred":"hp_id","subj":"T329","obj":"http://purl.obolibrary.org/obo/HP_0002027"}],"text":" Wen, 202033All Shenzhen CityGuangdongDates: 1/1/2020-2/28/2020Last follow-up: 2/28/2020 n = 417Survival: 0.7% died, 71.7% discharged, 27.6% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR.Age: m 45.4 ySex: 52.8% femalesGI/liver comorbidities: NRDisease severity: 8.9% mild, 82.5% moderate, 8.6% severe/critical Diarrhea: 7.0% (29)Present on admission.23/381 of mild/moderates and 6/36 of severe/criticalNausea, vomiting, and abdominal pain: NR ALT, AST, and bilirubin: NR"}

{"project":"LitCovid-sentences","denotations":[{"id":"T632","span":{"begin":0,"end":44},"obj":"Sentence"},{"id":"T633","span":{"begin":45,"end":78},"obj":"Sentence"},{"id":"T634","span":{"begin":79,"end":105},"obj":"Sentence"},{"id":"T635","span":{"begin":106,"end":170},"obj":"Sentence"},{"id":"T636","span":{"begin":171,"end":229},"obj":"Sentence"},{"id":"T637","span":{"begin":230,"end":286},"obj":"Sentence"},{"id":"T638","span":{"begin":287,"end":344},"obj":"Sentence"},{"id":"T639","span":{"begin":345,"end":495},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" Wen, 202033All Shenzhen CityGuangdongDates: 1/1/2020-2/28/2020Last follow-up: 2/28/2020 n = 417Survival: 0.7% died, 71.7% discharged, 27.6% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR.Age: m 45.4 ySex: 52.8% femalesGI/liver comorbidities: NRDisease severity: 8.9% mild, 82.5% moderate, 8.6% severe/critical Diarrhea: 7.0% (29)Present on admission.23/381 of mild/moderates and 6/36 of severe/criticalNausea, vomiting, and abdominal pain: NR ALT, AST, and bilirubin: NR"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2439","span":{"begin":187,"end":195},"obj":"Disease"},{"id":"2440","span":{"begin":335,"end":343},"obj":"Disease"},{"id":"2441","span":{"begin":419,"end":433},"obj":"Disease"},{"id":"2442","span":{"begin":435,"end":443},"obj":"Disease"},{"id":"2443","span":{"begin":449,"end":463},"obj":"Disease"}],"attributes":[{"id":"A2439","pred":"tao:has_database_id","subj":"2439","obj":"MESH:C000657245"},{"id":"A2440","pred":"tao:has_database_id","subj":"2440","obj":"MESH:D003967"},{"id":"A2442","pred":"tao:has_database_id","subj":"2442","obj":"MESH:D014839"},{"id":"A2443","pred":"tao:has_database_id","subj":"2443","obj":"MESH:D015746"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" Wen, 202033All Shenzhen CityGuangdongDates: 1/1/2020-2/28/2020Last follow-up: 2/28/2020 n = 417Survival: 0.7% died, 71.7% discharged, 27.6% still hospitalized.Inclusion: Inpatients with COVID-19 based on RT-PCR.Age: m 45.4 ySex: 52.8% femalesGI/liver comorbidities: NRDisease severity: 8.9% mild, 82.5% moderate, 8.6% severe/critical Diarrhea: 7.0% (29)Present on admission.23/381 of mild/moderates and 6/36 of severe/criticalNausea, vomiting, and abdominal pain: NR ALT, AST, and bilirubin: NR"}